Contact Us

HEADQUARTERS

210 Main Street West
Baudette, MN 56623
Phone: 218-634-3500
Fax: 218-634-3540

Contacts

Phone: 1-800-434-1121
Email: info@anipharmaceuticals.com
To report an adverse event or for medical inquiries please see contact information below.

For Rare Disease Products

Purified Cortrophin® Gel (repository corticotropin injection USP)
Phone: 1-800-308-6755
Adverse Event Email: drugsafety@anipharmaceuticals.com
Product Quality Complaints: complaints@anipharmaceuticals.com

Iluvien® (fluocinolone acetonide intravitreal implant)
Yutiq® (fluocinolone acetonide intravitreal implant)
Phone: 1-844-445-8843
Fax: 1-678-990-5740
Email: pvalimerasciences@alimerasciences.com

For Established Brands/Specialty Therapeutics Products

Arimidex® (anastrozole) Tablets
Atacand® (candesartan cilexetil) Tablets
Atacand HCT® (candesartan cilexetil-hydrochlorothiazide) Tablets
Casodex® (bicalutamide) Tablets
Cortenema® (hydrocortisone retention enema)
Inderal® LA (propranolol hydrochloride) Long-Acting Capsules
Inderal® XL (propranolol hydrochloride) Extended-Release Capsules
InnoPran XL® (propranolol hydrochloride) Extended-Release Capsules
Lithobid® (lithium carbonate USP) Extended-Release Tablets
Oxistat® (oxiconazole nitrate) Lotion
Vancocin® (vancomycin hydrochloride) Capsules USP
Vancomycin Hydrochloride for Oral Solution USP
Veregen® (sinecatechins) Ointment
Phone: 1-800-308-6755
Adverse Event Email: drugsafety@anipharmaceuticals.com
Product Quality Complaints: complaints@anipharmaceuticals.com

For all other ANI Pharmaceuticals/Novitium Pharma Products

Phone: 1-855-204-1431
Adverse Event Email: drugsafety@anipharmaceuticals.com
Product Quality Complaints: complaints@anipharmaceuticals.com

Adverse events may also be reported to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

For Business Development, Contract Manufacturing, and Specialty Sales

Please contact: Chad Gassert
Phone: 1-800-434-1121
Email: chad.gassert@anipharmaceuticals.com

For Sales Inquiries

Phone: 1-800-434-1121
Email: Sales@anipharmaceuticals.com

For Investor Relations Inquiries

Please contact: Lisa M. Wilson, In-Site Communications, Inc.
Phone: 212-452-2793
Email: IR@anipharmaceuticals.com